EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.5.1.9 | Brucellosis |
30927485 |
A high-throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 2.5.1.9 | Endocarditis |
15297484 |
Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. |
unassigned |
0 |
| 2.5.1.9 | Iron Deficiencies |
834 |
[Biosynthesis of flavins and its regulation in the yeast Pichia guilliermondii] |
ongoing research
unassigned |
2
0 |
| 2.5.1.9 | Tuberculosis |
17696548 |
Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase. |
unassigned |
0 |
| 2.5.1.9 | Tuberculosis |
18331058 |
A New Series of N-[2,4-Dioxo-6-d-ribitylamino-1,2,3,4-tetrahydropyrimidin-5-yl]oxalamic Acid Derivatives as Inhibitors of Lumazine Synthase and Riboflavin Synthase: Design, Synthesis, Biochemical Evaluation, Crystallography, and Mechanistic Implications. |
therapeutic application
unassigned |
3
0 |
| 2.5.1.9 | Tuberculosis |
19545132 |
Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis. |
therapeutic application
unassigned |
3
0 |
